Gå til innholdet
Menu

PHARMAQ and Zoetis introduce innovative vaccine to key stakeholders at a special event in Chile

PHARMAQ and Zoetis leaders came together in Puerto Montt, Chile last week to celebrate and promote the launch of ALPHA JECT LiVac® SRS, an innovative vaccine that helps control Salmon Rickettsial Septicaemia (SRS) Syndrome.

The new vaccine represents a significant milestone, one that was achieved after many years of hard work and focus by the PHARMAQ R&D team to address an unmet need in the Chilean market. The launch event was attended by fish farming company leaders, industry and government officials, financial analysts and trade and national media reporters.

Zoetis CEO, Juan Ramón Alaix began the event by expressing our company’s commitment to aquatic health and acknowledging the excellent work of the PHARMAQ team who delivered the firstattenuated live SRS vaccine with the support of customers and Chilean regulatory authorities. Morten Nordstad, PHARMAQ President, presented details about the history of the R&D project and the ground-breaking vaccine.  PHARMAQ colleagues, Frode Finne-Fridell and Rolf Hetlelid Olsen, from the R&D team also shared specifics regarding product safety and efficacy.

“I am very proud that PHARMAQ is the first company to deliver an attenuated live SRS vaccine that will help customers develop a sustainable and profitable salmon industry,” said Morten Nordstad. The approval was achieved in record time and is the result of a great team effort, thanks to everyone involved for a fantastic contribution to bring this product to our customers in the Chilean market!” 

External speakers provided industry insights and expertise from the Chilean National Fishery and Aquaculture Service, Salmones Multiexport, and Nordea Markets during the event as well.

About SRS and the ALPHA JECT LiVac® SRS Vaccine

SRS is considered to be the most prevalent disease in the Chilean salmon farming industry. The disease is caused by the bacterium Piscirickettsia salmonis, generating a severe disease that has caused major economic losses in the aquaculture industry since its appearance in 1989. The disease is known to affect three species of fish, Atlantic salmon, rainbow trout and Coho salmon. ALPHA JECT LiVac® SRS is the first attenuated live vaccine to ensure a high level of protection against SRS. It is safe for fish and the environment and was developed to improve the sustainability of Chilean salmon farming.

Did you know...

WE MAKE AQUACULTURE PROGRESS

Newsfeed delivered by Meltwater News. PHARMAQ is not to be held liable for any of its content nor possible incorrect information given.

»
»
»
»
»
»
»
»
»
»

Norway

PHARMAQ AS
Head office/
Production facility
Skogmo Industriområde
Industrivegen 50
N-7863 Overhalla, Norway
Tel:+47 74 28 08 00
customer.service​@pharmaq.no


PHARMAQ AS
Production facility
Dyrskuevien 13, 2040 Kløfta
P.O.Box 152, N-2041 Kløfta, Norway
Tel: +47 23 29 85 00
customer.service​@pharmaq.no

   

PHARMAQ AS
Harbitzalléen 2A, 0275 Oslo
P.O.Box 267 Skøyen
N-0213 Oslo, Norway
Tel: +47 23 29 85 00
customer.service​@pharmaq.no

   

PHARMAQ Analytiq
Thormøhlensgate 53D
N-5008 Bergen, Norway
Tel: (+47) 23 29 85 00
kontakt@analytiq.no

   

PHARMAQ Fishteq
Havneveien 6
N-8700 Nesna, Norway
Tel:+47 941 63 150
PHQ.fishteqsupport@zoetis.com

Chile

PHARMAQ AS Chile Ltda.
Bernardino # 1981, Piso 2, Oficina 202,
Parque Empresarial San Andrés,
Puerto Montt, Chile
Tel: +56 65 248 3091
customer.service​@pharmaq.no

 

United Kingdom

PHARMAQ Ltd.
Unit 15 Sandleheath Industrial Estate,
Fordingbridge,
Hampshire SP6 1PA,
United Kingdom
Tel: +44 1425 656081
orders@pharmaq.no

Terms & Conditions of Purchase
Terms & Conditions of Sale
Tax strategy and Disclosure: Financial year ending 30 November 2017

Turkey

PHARMAQ Veteriner Ecza Deposu ve Su Ürünleri Tic.Ltd.Şti
KARACAOGLAN MAH. 6166 SK. 21 A BORNOVA/ IZMIR Turkiye
Tel: +90 232 422 23 10
customer.service​@pharmaq.no

Vietnam

PHARMAQ Ltd. VN
R. 2503, 25th Fl., Viettel Tower
285 Cach Mang Thang Tom
W.12, D10, HCMC, Vietnam
Tel : +84 28 6284 5350
customer.service​@pharmaq.no

Panama

Zoetis Panamá / PHARMAQ Panamá
Piso 2. Oficina 108. P.H. Albrook Commercial Park
Ave. Bella Vista, Ancón, Panamá
PO. Box: 0832-0588
Phone: +507 3215363
Mob.: +507 6675 1109
customer.service​@pharmaq.no

Spain

PHARMAQ Spain Aqua
Avda de Europa 20B
Parque Empresarial La Moraleja
28108 Alcobendas, Spain
Tel: +34 91 419 19 35
customer.service​@pharmaq.no

Singapore

PHARMAQ part of Zoetis
108 Pasir Panjang Road
Singapore 118535, Singapore
Tel.: +65 6933 5800
customer.service​@pharmaq.no

PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. Production facilities, administration and research and development activities are based in Norway with subsidiaries in Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 300 employees. The company's products are marketed in Europe, North and South America, and Asia. For further information, visit the company's website at www.pharmaq.comPrivacy Policy. Cookie Policy. Terms of Use.

Copyright © 2016 Zoetis LLC. All rights reserved.

Utviklet av Imaker as